Research Output

Filter
Editorial
2019

Compound mutations in CML—imaginary bogeyman or real arch-nemesis?

Yeung, D., 1 Jun 2019, In : Leukemia Research. 81, p. 102-104 3 p.

Research output: Contribution to journalEditorial

Predicting response to new drugs in AML from simulation modelling: Value of the BEAT AML project as a validation resource

Benard, B. & Thomas, D., 1 May 2019, In : Leukemia Research. 80, p. 43-44 2 p.

Research output: Contribution to journalEditorial

Body Mass Index in Children Validated by Metabolic and Fat Mass Profiling

Makinen, V-P., 18 Dec 2018, In : Journal of the American College of Cardiology. 72, 24, p. 3155-3157 3 p.

Research output: Contribution to journalEditorial

Endothelin receptor emerges as a potential target of Hoxa9-mediated leukemogenesis

Gars, E., Kaur, S. & Thomas, D., 1 Dec 2018, In : Leukemia Research. 75, p. 69-70 2 p.

Research output: Contribution to journalEditorial

Osteopontin in the pathophysiology of obesity: Is Opn a fat cell foe?

Fitter, S. & Zannettino, A., 1 May 2018, In : Obesity Research and Clinical Practice. 12, 3, p. 249-250 2 p.

Research output: Contribution to journalEditorial

2017

Comment on “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study”

Hughes, A., Clarson, J., Gargett, T., Yu, W., Brown, M. P., Lopez, A. F., Hughes, T. P. & Yong, A. S. M., 1 Apr 2017, In : Leukemia Research. 55, p. 55-57 3 p.

Research output: Contribution to journalEditorial

2 Citations (Scopus)

Systems approaches for identifying disease genes and drug targets

Srihari, S., 1 Dec 2017, In : Methods. 131, p. 1-3 3 p.

Research output: Contribution to journalEditorial

2015

Microbiology review series: CF microbiology - Towards 2020 and beyond

Rogers, G. & Tunney, M. M., 1 May 2015, In : Journal of Cystic Fibrosis. 14, 3, p. 289-290 2 p.

Research output: Contribution to journalEditorial

2013

New strategies and compounds for anti-infective treatment

Hancock, R. & Sahl, H. G., 1 Oct 2013, In : Current Opinion in Microbiology. 16, 5, p. 519-521 3 p.

Research output: Contribution to journalEditorial

20 Citations (Scopus)
2009

Synchronous Colorectal Cancer: Not Just Bad Luck?

Leggett, B. A. & Worthley, D. L., 1 Jan 2009, In : Gastroenterology. 137, 5, p. 1559-1562 4 p.

Research output: Contribution to journalEditorial

14 Citations (Scopus)
2008

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features

Cross, N. C. P., Daley, G. Q., Green, A. R., Hughes, T. P., Jamieson, C., Manley, P., Mughal, T., Perrotti, D., Radich, J., Skoda, R., Soverini, S., Vainchenker, W., Verstovsek, S., Villeval, J. L. & Goldman, J. M., 1 Jan 2008, In : Leukemia. 22, 11, p. 1975-1989 15 p.

Research output: Contribution to journalEditorial

14 Citations (Scopus)
2006

Mannose-binding lectin and maladies of the bowel and liver

Worthley, D. L., Bardy, P. G., Gordon, D. L. & Mullighan, C. G., 28 Oct 2006, In : World Journal of Gastroenterology. 12, 40, p. 6420-6428 9 p.

Research output: Contribution to journalEditorial

14 Citations (Scopus)
1999

Host defence (cationic) peptides. What is their future clinical potential?

Hancock, R., 6 May 1999, In : Drugs. 57, 4, p. 469-473 5 p.

Research output: Contribution to journalEditorial

117 Citations (Scopus)